UNSPSC 51282802: Coumamycin

This classification denotes an antibiotic with the molecular formula C55H59N5O20, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, PCH9QZ1IIH chemically known as 5-methylpyyrole-2-carboxylic acid, diester with 3,3'-((3-methylpyrrole-2,4-diyl)bis(carbonylimino))bis(4-hydroxy-8-methyl-7-((tetrahydro-3,4-dihydroxy-5-methoxy-6,6-dimethylpyran-2-yl)oxy)coumarin) but generally known as coumamycin, which bears US NIH Compound Identifier 20494.

UNSPSC 51282802 Coumamycin, a Commodity code, does not reflect the actual procurement activity currently being solicited under this classification. The recent opportunities posted under this code involve naloxone, safe drug deactivation systems, medical and first aid supplies for emergency response, generic pharmaceuticals and over-the-counter products distributed through authorized wholesalers, and direct-to-manufacturer prescription programs — none of which are coumamycin-specific pharmaceuticals. State and local health departments, emergency management agencies, fire departments, and pharmacy benefit programs are using this code to solicit medical supplies, emergency response consumables, and pharmaceutical distribution services that bear no substantive relationship to the code's nominal scope. The mismatch between the code label and the work actually being bought suggests either a cataloging error in the source data or persistent misuse of the code designation in state and local procurement systems.

The geographic spread spans Florida (Seminole County), Texas (Health and Human Services Commission), Minnesota (MMCAP cooperative vehicle serving Minnesota and Oregon), and the City of Tampa. Seminole County issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2026. The City of Tampa issued ITB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, designated as a sheltered market opportunity for certified Small Local Business Enterprises with an estimated contract value of $700,000. Minnesota's MMCAP cooperative issued RFP S1070000015802 on January 20, 2026, with a March 26, 2026 deadline, for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities for a direct-to-manufacturer prescription program. The code shows little relevant recent activity and significant categorical misalignment with what state and local government is actually procuring.